<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="utf-8">

    <title>Notitia | Investors & News</title>
    <meta name="description" content="Homepage for NotitiaBio">
    <meta name="author" content="Notitia">
    <meta name="viewport" content="width=device-width, initial-scale=1">


    <link rel="stylesheet" href="style.css">
    <link rel="icon" href="images/small-logo.png" type="image/png">

    <link rel="stylesheet" href="https://unpkg.com/aos@next/dist/aos.css" />
    <script src="https://kit.fontawesome.com/5d869ca34c.js" crossorigin="anonymous"></script>


</head>
<nav class="sidenav">
    <img src="images/Original.svg" alt="notitia logo">
    <a href="index.html">Home</a>
    <a href="about.html">About us</a>
    <a href="science.html">Our Science</a>
    <a href="general-public.html">General Public</a>
    <a href="patients.html">Patients</a>
    <a href="#" class="active">Investor & News</a>

<!--
    <div class="social-media">
        <a href="#"><i class="fab fa-facebook-square"></i></a>
        <a href="#"><i class="fab fa-instagram-square"></i></a>
        <a href="#"><i class="fab fa-twitter-square"></i></a>
    </div>
-->
</nav>
<div class="hamburger">
    <div></div>
    <div></div>
    <div></div>
</div>  
<main>
    <button class="contact-us" id="contact-us">Contact Us</button>

    <section class="hero investors-hero">
        <div class="text-container">
            <h1>Investors & News</h1>
        </div>
    </section>
<div class="gutter"></div>
<div class="full hero-text">
    Stay Up to Date with Notitia's Latest Clinical Trials and Other Developments
</div>
    <section class="grid news">
        <div class="square white">
            <h1>NBT-NM108
                Phase 2a</h1>
        </div>
        <div>
            <h4>Notitia Biotechnologies Receives Approval from FDA for Phase 2a Clinical Trial in Diabetic & Prediabetic Patients
            </h4>
            <div class="caption">August 14, 2020</div>
            <p>
                Notitia Biotechnologies Company has received the Investigational New Drug (IND) approval from the FDA for NBT-NM108, a proprietary formula designed to support the Foundation Guild bacteria in the patient's gut microbiome. The FDA has allowed Notitia to test the drug as a treatment for COVID-19 in patients with type 2 diabetes and prediabetes. Notitia has secured funding for a Phase 2a randomized, controlled clinical trial, and the study will be performed in the Tampa Florida area. Enrollment is expected to begin by October, and further information regarding the study is available on clinicaltrials.gov.
                <br><br>
                For more information regarding Notitia's Foundation Guild Microbiome R&D Platform, please click here. For more information about the NBT-NM108's development pipeline, please click here. 

            </p>
        </div>
            
    </section>

        <!-- The Modal -->
        <div id="contact-us-modal" class="modal">
            <!-- Modal content -->
            <div class="contact-modal-content">
                <form class="contact" action="https://submit-form.com/kguz4w2C" target="_self"> 
                    <!-- <form class="contact" action="https://usebasin.com/f/568c9b065574" target="_self"> -->
                    <span class="close">&times;</span>
                    <h1>Contact Us</h1>               
                    <label for="name">Name</label><br>
                    <input type="text" id="name" name="name"><br>
                    <label for="email">Email</label><br>
                    <input type="email" id="email" name="email">
                    <label for="phone">Phone</label><br>
                    <input type="number" id="phone" name="phone">
    
                    <label for="message">Message</label><br>
                    <textarea type="text" id="message" name="message"></textarea>
    
                    <form action="?" method="POST">
                        <div class="g-recaptcha" data-sitekey="6LeHPDYaAAAAAI_xDWPLq2cwYnbhD6i-69OWOSuw
                        "></div>
                        <br/>
                        <input type="submit" value="Submit">
                      </form>
                    <input type="submit">
                </form>
            </div>
        </div>
    <footer>
        Copyright &copy; 2021 Notitia Biotechnologies. All Rights Reserved.
    </footer>
    <script src="https://code.jquery.com/jquery-3.5.1.slim.min.js"
        integrity="sha256-4+XzXVhsDmqanXGHaHvgh1gMQKX40OUvDEBTu8JcmNs=" crossorigin="anonymous"></script>
    <script src="js/main.js"></script>
    <script src="https://www.google.com/recaptcha/api.js" async defer></script>
    <script src="https://unpkg.com/aos@next/dist/aos.js"></script>
    <script>
        AOS.init({
            //anchorPlacement: "bottom-center",
            offset: 200,
            duration: 1000,
        });
    </script>

</main>

</html>